Skip to main content

WPI 3722 (Lamotrigine (Orally Disintegrating) 50 mg)

Pill with imprint WPI 3722 is White, Round and has been identified as Lamotrigine (Orally Disintegrating) 50 mg. It is supplied by Global Pharmaceuticals.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3722

Lamotrigine (orally disintegrating) 50 mg WPI 3722

Lamotrigine (Orally Disintegrating)

Imprint
WPI 3722
Strength
50 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceuticals
National Drug Code (NDC)
00115-1527 (Discontinued)
Inactive Ingredients
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer, aspartame, silicon dioxide, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, corn starch, sodium chloride, stearic acid

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.